Trademark: E 2402551
Word
E
Device Descrption:
LTR E,SEGMENTED IS PART OF HEXAGON
ID
2402551
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
22 June 2023
Registration Date
22 June 2023
Renewal Date
22 June 2033

Owner(s)
Service
Davies Collison Cave Pty Ltd

Goods and Services:
Class 5:
Pharmaceuticals; pharmaceutical drugs; dermatological pharmaceutical products; pharmaceutical preparations; dermatological pharmaceutical substances; pharmaceutical compositions; antidiabetic pharmaceuticals; anti-diabetic pharmaceuticals; cardiovascular pharmaceuticals; injectable pharmaceuticals; tissue-regenerative pharmaceutical preparations; cardiovascular pharmaceutical preparations; antibacterial pharmaceuticals; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; anaesthetic preparations for inhalation; pharmaceutical preparations for inhalers; sanitary preparations and articles; hygienic preparations and articles; air deodorising and air purifying preparations; dental preparations; dental articles, namely materials for tooth restoration, dental cements, dental filling materials, bone fillers consisting of living materials as well as bone growth media consisting of biological materials for medical purposes; medicated dentifrices; dietary supplements and dietetic preparations; pest control preparations and articles; pharmaceutical preparations for the treatment of kidney diseases; respiratory stimulants; compounds for treating correlated pulmonary syndromes; medicines for the treatment of cardiovascular and cerebrovascular diseases; fertility enhancement preparations; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; autoantigens; vaccines; vaccine preparations; vaccine adjuvants; veterinary vaccines; vaccines against pneumococcal infections; viral vaccines; human vaccine preparations; vaccines against flu; oral vaccine preparations; antiviral drugs for treating influenza; vaccines for human use; fat emulsions for medical infusions; medical preparations; medicinal healthcare preparations; medicinal infusions; infusions (medicinal -); medicinal preparations and substances; medicine; serotherapeutic medicines; antiallergic medicines; medicines for animals; nucleic acid sequences for medical and veterinary purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; cellular function activating agents for medical purposes; chemical preparations for medical purposes; chemical preparations for veterinary purposes; nasal sprays for medical purposes; medicated nasal spray preparations; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; compounds for treating cancer; pharmaceutical preparations for activating cellular function.